Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 303 citations
Electronic publication date
February 25, 2011

View on Pubmed.gov 21097505 | View on doi.org 10.1074/jbc.M11...

The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1).

Search for publications in this journal J Biol Chem - 286(3):1786-94

Abstract

Macrophages play a central role in the balance and efficiency of the immune response and are at the interface between innate and adaptive immunity. Their phenotype is a delicate equilibrium between the M1 (classical, pro-Th(1)) and M2 (alternative, pro-Th(2)) profiles. This balance is regulated by cytokines such as interleukin 13 (IL-13), a typical pro-M2-Th(2) cytokine that has been related to allergic disease and asthma. IL-13 binds to IL-13 receptor α1 (IL13Rα1), a component of the Type II IL-4 receptor, and exerts its effects by activating the transcription factor signal transducer and activator of transcription 6 (STAT6) through phosphorylation. MicroRNAs are short (∼22 nucleotide) inhibitory non-coding RNAs that block the translation or promote the degradation of their specific mRNA targets. By bioinformatics analysis, we found that microRNA-155 (miR-155) is predicted to target IL13Rα1. This suggested that miR-155 might be involved in the regulation of the M1/M2 balance in macrophages by modulating IL-13 effects. miR-155 has been implicated in the development of a healthy immune system and function as well as in the inflammatory pro-Th(1)/M1 immune profile. Here we have shown that in human macrophages, miR-155 directly targets IL13Rα1 and reduces the levels of IL13Rα1 protein, leading to diminished activation of STAT6. Finally we also demonstrate that miR-155 affects the IL-13-dependent regulation of several genes (SOCS1, DC-SIGN, CCL18, CD23, and SERPINE) involved in the establishment of an M2/pro-Th(2) phenotype in macrophages. Our work shows a central role for miR-155 in determining the M2 phenotype in human macrophages.

References

J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1063-70

J Biol Chem. 2010 Dec 31;285(53):41328-36

Trends Immunol. 2002 Nov;23(11):549-55

Immunity. 2002 Nov;17(5):583-91

Cited by 303 citations (total)

Journal Article Research Support, N.I.H., Extramural

Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.

Electronic publication date May 30, 2012

Search for publications in this journal PLoS One

Seema Singh [...] Don M Wojchowski et al.

Erythropoietin (EPO) and its cell surface receptor (EPOR) are essential for erythropoiesis; can modulate non-erythroid target tissues; and have been...

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.

Electronic publication date July 10, 2013

Search for publications in this journal Immunity

Jan C Dudda [...] Pedro Romero et al.

MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) T cell immunity remains unknown. Here...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances